ORCID
- Felmlee, Daniel: 0000-0001-8350-122X
Abstract
Hepatitis C virus (HCV) is a leading cause of chronic liver disease, including chronic hepatitis, fibrosis, cirrhosis, and hepatocellular carcinoma. Hepatitis C infection associates with lipid and lipoprotein metabolism disorders such as hepatic steatosis, hypobetalipoproteinemia, and hypocholesterolemia. Furthermore, virus production is dependent on hepatic very-low-density lipoprotein (VLDL) assembly, and circulating virions are physically associated with lipoproteins in complexes termed lipoviral particles. Evidence has indicated several functional roles for the formation of these complexes, including co-opting of lipoprotein receptors for attachment and entry, concealing epitopes to facilitate immune escape, and hijacking host factors for HCV maturation and secretion. Here, we review the evidence surrounding pathogenesis of the hepatitis C infection regarding lipoprotein engagement, cholesterol and triglyceride regulation, and the molecular mechanisms underlying these effects.
DOI
10.3390/v5051292
Publication Date
2013-05-23
Publication Title
Viruses
Volume
5
Issue
5
First Page
1292
Last Page
1324
ISSN
1999-4915
Organisational Unit
Peninsula Medical School
Recommended Citation
Felmlee, D. J., Hafirassou, M., Lefevre, M., Baumert, T., & Schuster, C. (2013) 'Hepatitis C Virus, Cholesterol and Lipoproteins — Impact for the Viral Life Cycle and Pathogenesis of Liver Disease', Viruses, 5(5), pp. 1292-1324. Available at: https://doi.org/10.3390/v5051292
